Fetal Hemoglobin Breakthrough
Victoria's journey takes a hopeful turn as her genetically modified cells begin producing fetal hemoglobin, a crucial protein that could alleviate her sickle cell disease. The conversation dives into the science behind hemoglobin and the innovative use of CRISPR technology to potentially restore normal function in patients. With excitement in the air, the implications of this breakthrough could change lives and redefine treatment for sickle cell disease.In this clip
From this podcast
Short Wave
That Revolutionary Gene-Editing Experiment? So Far So Good.
Related Questions